Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ASX-listed renal specialist Dimerix Limited (ASX: DXB)Mission will receive up to U ...

Telegram Serverless lets developers deploy bot backends on Telegram's own infrastructure with a single tgcloud command, but ...

Spread the love“`html Google Sheets has become a go-to tool for individuals and businesses alike, thanks to its powerful ...

Nature Medicine today featured on its cover the findings from The Feinstein Institutes for Medical Research, demonstrating ...

Maximize development velocity and eliminate operations toil with this indie-favorite serverless, event-driven, no-ops stack.